Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03145662
Other study ID # HPB vs CB
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date March 23, 2017
Est. completion date March 23, 2019

Study information

Verified date June 2024
Source University of Toledo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients suspected of having AV access stenosis will be referred to the Division of Vascular and Endovascular Surgery by the dialysis center. Patients with signs of AV access failure who are found to have significant stenosis (more than 50%) at the venous end of the anastomosis will then be randomized to either high pressure balloon (Conquest) or to a cutting balloon (Boston scientific Balloon). Angiograms will then be performed before and after intervention.


Description:

Patients suspected of having AV access stenosis will be referred to the Division of Vascular and Endovascular Surgery by the dialysis center. Patients with signs of AV access failure who are found to have significant stenosis (more than 50%) at the venous end of the anastomosis will then be randomized to either high pressure balloon (Conquest) or to a cutting balloon (Boston scientific Balloon). Angiograms will then be performed before and after intervention. Data will be collected from standard of care visit, including physician visits and ultrasounds. Follow up will be based on the function of the AV access, dialysis center criteria and/or standard of care ultrasound results: including venous pressure of the AV access, difficult cannulation, urea recirculation, and change in character and sound of the AV access (thrill/bruit), which are standard of care assessment at a dialysis center. All patient data sheets will be kept in a study binder and locked in the research room. Randomization will be performed with a computer program.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date March 23, 2019
Est. primary completion date March 23, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Age = 18 years of age 2. AV fistula or graft 3. Undergoing weekly hemodialysis 4. Patients must agree to the terms of the study and sign an informed Consent Exclusion Criteria: 1. Pregnant women

Study Design


Related Conditions & MeSH terms


Intervention

Device:
high pressure balloon
high pressure balloon will be used to treat stenosis
cutting balloon
cutting balloon will be used to treat stenosis

Locations

Country Name City State
United States UTMC Toledo Ohio

Sponsors (1)

Lead Sponsor Collaborator
University of Toledo Health Science Campus

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stenosis Rate days of stenosis free period 2 years
See also
  Status Clinical Trial Phase
Completed NCT04103177 - Physical Activity in Haemodialysis Patients: a Feasibility Study N/A
Completed NCT01561118 - DiaSport - Endurance-orientated Training Program With Children and Adolescents on Maintenance Hemodialysis N/A
Withdrawn NCT03645720 - The Prognosis of Graft Using Plastic Cannula in Hemodialysis N/A
Active, not recruiting NCT02598635 - Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis Phase 4
Terminated NCT01643733 - Study on Fistuloplasty Using Flow Measurement Guidance N/A
Not yet recruiting NCT03169400 - Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) N/A
Completed NCT02439697 - A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients N/A
Completed NCT02063490 - Nurse-led Intervention to Improve Phosphate Binder Adherence N/A
Completed NCT04106310 - Theranova vs High-flux HD Comparison N/A
Recruiting NCT06056102 - CAR-T Cell Therapy for Desensitization in Kidney Transplantation Phase 1
Completed NCT04698512 - MAgicTouchâ„¢ Intervention Leap for Dialysis Access (MATILDA) Trial
Completed NCT02819011 - OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO Phase 2
Completed NCT02484118 - Hemodialysis Blood Flow and Urea Clearance N/A
Enrolling by invitation NCT01641757 - Effect of Non-Surgical Periodontal Therapy on Serum Albumin Levels of Patients on Maintenance Hemodialysis Therapy, Phase 2
Completed NCT03172039 - Antimicrobial Use and Stewardship in an Outpatient Hemodialysis Unit N/A
Completed NCT03897231 - Prevalence of Non-adherence to Medication Among Patients on Chronic Hemodialysis
Completed NCT02621918 - The Effects of Exercise in End-stage Renal Disease Patients Undergoing Hemodialysis N/A
Completed NCT01356615 - Low Molecular Weight Heparin for Hemodialysis Anticoagulation N/A
Terminated NCT01033357 - Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access N/A
Recruiting NCT05927532 - Argyle Safety Fistula Cannula With Anti-reflux Valve Clinical Study N/A